SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-264141
Filing Date
2019-10-08
Accepted
2019-10-08 09:05:36
Documents
3
Period of Report
2019-10-05
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d38016d8k.htm 8-K 28187
2 EX-10.1 d38016dex101.htm EX-10.1 15346
3 EX-10.2 d38016dex102.htm EX-10.2 53277
  Complete submission text file 0001193125-19-264141.txt   98207
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 191141880
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences